ProcDNA Named a Major Contender in Everest Group’s Life Sciences AI and Analytics for Commercial PEAK

ProcDNA has been recognized as a Major Contender in Everest Group’s Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Assessment 2025.

Everest Group’s PEAK Matrix® is an authoritative, multi-dimensional framework that assesses global service providers across market impact (adoption, portfolio mix, and client value) and vision and capability (innovation, domain investments, delivery footprint, and technical depth). Earning a spot as a Major Contender highlights ProcDNA’s rapid rise as a trusted analytics and AI partner to global pharmaceutical and biotech organizations. By combining deep commercial acumen with cutting-edge machine learning and Generative AI, our teams help life sciences brands streamline sales force strategy, optimize omnichannel HCP engagement, and uncover actionable patient insights.

This recognition validates our vision of modernizing commercial biopharma operations with agile, high-impact data solutions. We want to thank our clients for their continued partnership and trust in tackling their most complex commercial challenges, as well as our consultants, data scientists, and engineers for their relentless commitment to analytical rigor and delivery excellence.